Literature DB >> 23583216

Maternal soluble fms-like tyrosine kinase-1, placental growth factor, plasminogen activator inhibitor-2, and folate concentrations and early fetal size: the Generation R study.

Marieke I Bouwland-Both1, Eric A P Steegers, Jan Lindemans, Henk Russcher, Albert Hofman, Anneke J Geurts-Moespot, Fred C G J Sweep, Vincent W V Jaddoe, Régine P M Steegers-Theunissen.   

Abstract

OBJECTIVE: Fetal growth is dependent on adequate development of the placenta. Impaired angiogenesis and vasculogenesis in early pregnancy compromises placental and embryonic development. The proteins soluble fms-like tyrosine kinase (sFlt)-1, placental growth factor (PlGF), and plasminogen activator inhibitor (PAI)-2, and the B vitamin folate are determinants of placental development. This study aims to identify associations between these maternal biomarkers and early fetal size. STUDY
DESIGN: From a prospective birth cohort study in The Netherlands, 1491 pregnant women were selected for this study. At a mean gestational age (GA) of 12.4 weeks (SD 0.8) maternal venous blood samples were obtained to determine the concentrations of sFlt-1, PlGF, PAI-2, and folate. Early fetal size was assessed with measurement of the crown-to-rump length (CRL) at a mean of 12.4 weeks' GA (SD 0.8). Analyses were performed using multivariable linear regression analyses with the biomarkers (continuous, quintiles) as regressors and CRL as main outcome measure.
RESULTS: Linear trend analysis showed positive associations between maternal sFlt-1 (P < .001), PlGF (P = .042), PAI-2 (P < .001), and folate (P = .039) and CRL. These associations were independent of GA, maternal age, height, body mass index, ethnicity, fetal sex, parity, educational level, smoking, and folic acid supplement use (folate not adjusted).
CONCLUSION: sFlt-1, PlGF, PAI-2, and folate are positively associated with first-trimester fetal size.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  cohort study; early fetal size; folate; placental development; placental growth factor; plasminogen activator inhibitor-2; soluble fms-like tyrosine kinase-1

Mesh:

Substances:

Year:  2013        PMID: 23583216     DOI: 10.1016/j.ajog.2013.04.009

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  The Generation R Study: Biobank update 2015.

Authors:  Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2014-12-21       Impact factor: 8.082

2.  The profiles of soluble adhesion molecules in the "great obstetrical syndromes".

Authors:  Nikolina Docheva; Roberto Romero; Piya Chaemsaithong; Adi L Tarca; Gaurav Bhatti; Percy Pacora; Bogdan Panaitescu; Noppadol Chaiyasit; Tinnakorn Chaiworapongsa; Eli Maymon; Sonia S Hassan; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2018-02-01

3.  Sex-specific differences in fetal and infant growth patterns: a prospective population-based cohort study.

Authors:  Zoe A Broere-Brown; Esme Baan; Sarah Schalekamp-Timmermans; Bero O Verburg; Vincent W V Jaddoe; Eric A P Steegers
Journal:  Biol Sex Differ       Date:  2016-12-03       Impact factor: 5.027

4.  A prospective cohort study providing insights for markers of adverse pregnancy outcome in older mothers.

Authors:  Samantha C Lean; Rebecca L Jones; Stephen A Roberts; Alexander E P Heazell
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-20       Impact factor: 3.007

5.  Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.

Authors:  Henry Adekola; Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Zhong Dong; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-28

6.  Sex differences in the late first trimester human placenta transcriptome.

Authors:  Tania L Gonzalez; Tianyanxin Sun; Alexander F Koeppel; Bora Lee; Erica T Wang; Charles R Farber; Stephen S Rich; Lauren W Sundheimer; Rae A Buttle; Yii-Der Ida Chen; Jerome I Rotter; Stephen D Turner; John Williams; Mark O Goodarzi; Margareta D Pisarska
Journal:  Biol Sex Differ       Date:  2018-01-15       Impact factor: 5.027

7.  Lower S-adenosylmethionine levels and DNA hypomethylation of placental growth factor (PlGF) in placental tissue of early-onset preeclampsia-complicated pregnancies.

Authors:  Sandra G Heil; Emilie M Herzog; Pieter H Griffioen; Bertrand van Zelst; Sten P Willemsen; Yolanda B de Rijke; Regine P M Steegers-Theunissen; Eric A P Steegers
Journal:  PLoS One       Date:  2019-12-30       Impact factor: 3.240

8.  Environment-Wide Association Study (En WAS) of Prenatal and Perinatal Factors Associated With Autistic Traits: A Population-Based Study.

Authors:  Masoud Amiri; Sander Lamballais; Eloy Geenjaar; Laura M E Blanken; Hanan El Marroun; Henning Tiemeier; Tonya White
Journal:  Autism Res       Date:  2020-08-23       Impact factor: 5.216

9.  Maternal plasma soluble neuropilin-1 is downregulated in fetal growth restriction complicated by abnormal umbilical artery Doppler: a pilot study.

Authors:  B Porter; D Maulik; S Babbar; T Schrufer-Poland; J Allsworth; S Q Ye; D P Heruth; T Lei
Journal:  Ultrasound Obstet Gynecol       Date:  2021-11       Impact factor: 7.299

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.